tiprankstipranks
Trending News
More News >
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
Canadian Market
Advertisement

Origin Therapeutics Holdings, Inc. (SPLY) Price & Analysis

Compare
3 Followers

SPLY Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

8.28%91.72%
Mutual Funds
― Other Institutional Investors
91.72% Public Companies and
Individual Investors

SPLY FAQ

What was Origin Therapeutics Holdings, Inc.’s price range in the past 12 months?
Origin Therapeutics Holdings, Inc. lowest stock price was C$0.01 and its highest was C$0.13 in the past 12 months.
    What is Origin Therapeutics Holdings, Inc.’s market cap?
    Origin Therapeutics Holdings, Inc.’s market cap is C$15.21M.
      When is Origin Therapeutics Holdings, Inc.’s upcoming earnings report date?
      Origin Therapeutics Holdings, Inc.’s upcoming earnings report date is Sep 02, 2025 which is in 47 days.
        How were Origin Therapeutics Holdings, Inc.’s earnings last quarter?
        Currently, no data Available
        Is Origin Therapeutics Holdings, Inc. overvalued?
        According to Wall Street analysts Origin Therapeutics Holdings, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Origin Therapeutics Holdings, Inc. pay dividends?
          Origin Therapeutics Holdings, Inc. does not currently pay dividends.
          What is Origin Therapeutics Holdings, Inc.’s EPS estimate?
          Origin Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Origin Therapeutics Holdings, Inc. have?
          Origin Therapeutics Holdings, Inc. has 169,025,220 shares outstanding.
            What happened to Origin Therapeutics Holdings, Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Origin Therapeutics Holdings, Inc.?
            Currently, no hedge funds are holding shares in TSE:SPLY

            Company Description

            Origin Therapeutics Holdings, Inc.

            Origin Therapeutics Holdings Inc is an investment company primarily focusing on investments in the psychedelic industry. The Company plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution and sale of psychedelics and services related thereto.
            Similar Stocks
            Company
            Price & Change
            Follow
            Flow Capital Corp
            Esstra Industries
            ESG Global Impact Capital
            Torrent Capital Ltd
            The Western Investment Company of Canada Ltd
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis